35
Participants
Start Date
December 30, 2024
Primary Completion Date
March 27, 2026
Study Completion Date
March 27, 2026
Sonelokimab
Open label
RECRUITING
Clinical Site, Washington D.C.
RECRUITING
Clinical Site, Norfolk
RECRUITING
Clinical Site, Charleston
RECRUITING
Clinical Site, Sandy Springs
RECRUITING
Clinical Site, Macon
RECRUITING
Clinical Site, Hollywood
RECRUITING
Clinical Site, Miami
RECRUITING
Clinical Site, Murray
RECRUITING
Clinical Site, Columbus
RECRUITING
Clinical Site, Waterford
RECRUITING
Clinical Site, Fargo
RECRUITING
Clinical Site, Chicago
RECRUITING
Clinical Site, North Little Rock
RECRUITING
Clinical Site, Plano
RECRUITING
Clinical Site, San Antonio
RECRUITING
Clinical Site, Stanford
RECRUITING
Clinical Site, Dallas
Lead Sponsor
MoonLake Immunotherapeutics AG
INDUSTRY